Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
Trump’s Quantum Push Lifts IBM Stock as CEO Arvind Krishna Receives White House Praise 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
MENLO PARK, Calif., Feb. 17, 2016 -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2015, on Thursday, February 25, 2016, after the market close. Geron’s management will also host a conference call for analysts and investors on Thursday, February 25, 2016, at 4:30 p.m. Eastern Time to discuss the company’s fourth quarter and annual results and events.
Participants can access the conference call live via telephone by dialing 877-303-9139 (U.S.); 760-536-5195 (international). The conference ID is 48851221. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at http://edge.media-server.com/m/p/txcpdjvg. The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through March 26, 2016.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT: Anna Krassowska, Ph.D. Investor and Media Relations 650-473-7765 [email protected] [email protected]
